Fucosidosis Therapeutics Market

Fucosidosis therapeutics sales will grow through 2036, led by bone marrow transplantation at 47.6% of the therapy segment in 2026. Hospitals lead the end-use segment with a 62.3% share. The market was valued at USD 11.23 million in 2025, reaching USD 11.9 million in 2026 and USD 20.66 million by 2036.